{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:35:43Z","timestamp":1791362143837,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract\u00a0\u00a0<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Common side effects of taxane chemotherapy are nail toxicity and peripheral neuropathy (CIPN) causing severe impact on the quality of life. Different methods of cryotherapy to prevent these side effects have been tested. We investigated the use of machine-controlled cooling of hands and feet to reduce nail toxicity and CIPN in patients receiving taxane chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients receiving Docetaxel (planned dose <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\ge$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mo>\u2265<\/mml:mo>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula> 300\u00a0mg\/m<jats:sup>2<\/jats:sup>) or Paclitaxel (planned dose <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\ge$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mo>\u2265<\/mml:mo>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula> 720\u00a0mg\/m<jats:sup>2<\/jats:sup><jats:inline-formula><jats:alternatives><jats:tex-math>$$-$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mo>-<\/mml:mo>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula>) in the adjuvant or palliative setting of different cancers were included. The dominant hand and foot were cooled to approximately 10\u00a0\u00b0C using the Hilotherapy machine. The contralateral hand and foot were used as intrapatient comparison. The primary endpoint was the occurrence of any CIPN due to paclitaxel or nail toxicity due to Docetaxel. Both the intention to treat population (ITT) and the per protocol population (PPP) were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 69 patients, 21 treated with Docetaxel and 48 with Paclitaxel, were included at our centre between 08\/2020 and 08\/2022. Nail toxicity due to Docetaxel was overall not significantly improved by cooling in the ITT or PPP but a significant benefit across visits was found for the ITT. CIPN due to Paclitaxel was numerically better in the ITT and significantly better in the PPP. A significant benefit of cooling on CIPN occurrence across visits was found for the ITT and the PPP. Cooling was very well tolerated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cooling of hands and feet has a clinically meaningful impact on reducing occurrence of CIPN and nail toxicity on treatment with taxanes. Effects are more significant over time and are dose dependent.<\/jats:p>\n                <jats:p>Trial registration number.<\/jats:p>\n                <jats:p>2020\u201300381.<\/jats:p>\n                <jats:p>Date of registration.<\/jats:p>\n                <jats:p>24th February 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-024-08737-3","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:02:36Z","timestamp":1722060156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison"],"prefix":"10.1007","volume":"32","author":[{"given":"Kristen","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stoffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hayoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Rojas Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Fischer Maranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e4mer","family":"El Saadany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Hasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"von Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalea","family":"Patzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"issue":"3","key":"8737_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjd.13743","volume":"173","author":"K Capriotti","year":"2015","unstructured":"Capriotti K, Capriotti JA, Lessin S et al (2015) The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis. Br J Dermatol 173(3):842\u2013845. https:\/\/doi.org\/10.1111\/bjd.13743","journal-title":"Br J Dermatol"},{"issue":"5","key":"8737_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/WCO.0000000000000234","volume":"28","author":"G Cavaletti","year":"2015","unstructured":"Cavaletti G, Marmiroli P (2015) Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol 28(5):500\u2013507. https:\/\/doi.org\/10.1097\/WCO.0000000000000234","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"8737_CR3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","volume":"154","author":"DH Marks","year":"2018","unstructured":"Marks DH, Qureshi A, Friedman A (2018) Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review. JAMA Dermatol 154(12):1465\u20131472. https:\/\/doi.org\/10.1001\/jamadermatol.2018.3465","journal-title":"JAMA Dermatol"},{"issue":"1","key":"8737_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-016-3977-7","volume":"160","author":"S Tsuyuki","year":"2016","unstructured":"Tsuyuki S, Senda N, Kanng Y et al (2016) Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group. Breast Cancer Res Treat 160(1):61\u201367. https:\/\/doi.org\/10.1007\/s10549-016-3977-7","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"8737_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jnci\/djx178","volume":"110","author":"A Hanai","year":"2018","unstructured":"Hanai A, Ishiguro H, Sozu T et al (2018) Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial. J Natl Cancer Inst 110(2):141\u2013148. https:\/\/doi.org\/10.1093\/jnci\/djx178","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"8737_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdg050","volume":"14","author":"AM Minisini","year":"2003","unstructured":"Minisini AM, Tosti A, Sobrero AF et al (2003) Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 14(2):333\u2013337. https:\/\/doi.org\/10.1093\/annonc\/mdg050","journal-title":"Ann Oncol"},{"issue":"10","key":"8737_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00520-007-0232-0","volume":"15","author":"D Winther","year":"2007","unstructured":"Winther D, Saunte DM, Knap M, Haahr V, Jensen AB (2007) Nail changes due to docetaxel - a neglected side effect and nuisance for the patient. Support Care Cancer 15(10):1191\u20131197. https:\/\/doi.org\/10.1007\/s00520-007-0232-0","journal-title":"Support Care Cancer"},{"issue":"3","key":"8737_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejon.2011.06.007","volume":"16","author":"G Can","year":"2012","unstructured":"Can G, Aydiner A, Cavdar I (2012) Taxane-induced nail changes: predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. Eur J Oncol Nurs 16(3):270\u2013275. https:\/\/doi.org\/10.1016\/j.ejon.2011.06.007","journal-title":"Eur J Oncol Nurs"},{"issue":"5","key":"8737_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00520-013-2095-x","volume":"22","author":"AL McCarthy","year":"2014","unstructured":"McCarthy AL, Shaban RZ, Gillespie K, Vick J (2014) Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial. Support Care Cancer 22(5):1375\u20131383. https:\/\/doi.org\/10.1007\/s00520-013-2095-x","journal-title":"Support Care Cancer"},{"issue":"6","key":"8737_CR10","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jpainsymman.2013.07.014","volume":"47","author":"KC Kadakia","year":"2014","unstructured":"Kadakia KC, Rozell SA, Butala AA, Loprizini CL (2014) Supportive Cryotherapy: A Review from Head to Toe. J Pain Symptom Manag 47(6):1100\u20131115. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.07.014","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"8737_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3322\/caac.21204","volume":"63","author":"SB Park","year":"2013","unstructured":"Park SB, Goldstein D, Krishnan AV et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63(6):419\u2013437. https:\/\/doi.org\/10.3322\/caac.21204","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"8737_CR12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL, Lacchetti C, Dworkin RH et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 32(18):1941\u20131967. https:\/\/doi.org\/10.1200\/JCO.2013.54.0914","journal-title":"J Clin Oncol"},{"issue":"5","key":"8737_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/oxfordjournals.annonc.a059220","volume":"6","author":"TJ Postma","year":"1995","unstructured":"Postma TJ, Vermorken JB, Liefting AJM, Pinedo HM, Heimans JJ (1995) Paclitaxel-induced neuropathy. Ann Oncol 6(5):489\u2013494. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059220","journal-title":"Ann Oncol"},{"issue":"13","key":"8737_CR14","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-05-0298","volume":"11","author":"S Mielke","year":"2005","unstructured":"Mielke S, Sparreboom A, Steinberg SM et al (2005) Association of paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer. Clin Cancer Res 11(13):4843\u20134850. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0298","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8737_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-013-2728-2","volume":"142","author":"L Eckhoff","year":"2013","unstructured":"Eckhoff L, Knoop AS, Jensen MB, Ejlertsen B, Ewertz M (2013) Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer. Breast Cancer Res Treat 142(1):109\u2013118. https:\/\/doi.org\/10.1007\/s10549-013-2728-2","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"8737_CR16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461\u20132470. https:\/\/doi.org\/10.1016\/j.pain.2014.09.020","journal-title":"Pain"},{"issue":"4","key":"8737_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/0284186X.2015.1075664","volume":"55","author":"A Bandla","year":"2016","unstructured":"Bandla A, Sundar R, Liao L-D et al (2016) Hypothermia for preventing chemotherapy-induced neuropathy \u2013 a pilot study on safety and tolerability in healthy controls. Acta Oncol (Madr) 55(4):430\u2013436. https:\/\/doi.org\/10.3109\/0284186X.2015.1075664","journal-title":"Acta Oncol (Madr)"},{"issue":"1","key":"8737_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2015.11.011","volume":"140","author":"JR Brewer","year":"2016","unstructured":"Brewer JR, Morrison G, Dolan ME, Fleming GF (2016) Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol 140(1):176\u2013183. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.011","journal-title":"Gynecol Oncol"},{"issue":"8","key":"8737_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","volume":"22","author":"F Mols","year":"2014","unstructured":"Mols F, Beijers T, Vreugdenhil G, Van De Poll-Franse L (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 22(8):2261\u20132269. https:\/\/doi.org\/10.1007\/s00520-014-2255-7","journal-title":"Support Care Cancer"},{"issue":"11","key":"8737_CR20","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1007\/s00520-016-3329-5","volume":"24","author":"NR Zanville","year":"2016","unstructured":"Zanville NR, Nudelman KNH, Smith DJ et al (2016) Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment. Support Care Cancer 24(11):4779\u20134789. https:\/\/doi.org\/10.1007\/s00520-016-3329-5","journal-title":"Support Care Cancer"},{"issue":"958","key":"8737_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4869-5","volume":"18","author":"Z Ghoreishi","year":"2018","unstructured":"Ghoreishi Z, Keshavarz S, Asghari Jafarabadi M, Fathifar Z, Goodman KA, Esfahani A (2018) Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer. BMC Cancer 18(958):1\u20136. https:\/\/doi.org\/10.1186\/s12885-018-4869-5","journal-title":"BMC Cancer"},{"issue":"21","key":"8737_CR22","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1200\/JCO.2002.99.147","volume":"20","author":"S Spazzapan","year":"2002","unstructured":"Spazzapan S, Crivellari D, Lombardi D et al (2002) Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading? J Clin Oncol 20(21):4404\u20134405. https:\/\/doi.org\/10.1200\/JCO.2002.99.147","journal-title":"J Clin Oncol"},{"issue":"4","key":"8737_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","volume":"71","author":"KK Miller","year":"2014","unstructured":"Miller KK, Gorcey L, McLellan BN (2014) Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol 71(4):787\u2013794. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.019","journal-title":"J Am Acad Dermatol"},{"key":"8737_CR24","doi-asserted-by":"publisher","unstructured":"Michel, L., Romar, P., Feisst, M., Hamberger, D., Schwarz, D., Kurre, E., \u2026 Schneeweiss, A. (2022). 1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: first results of the prospective, randomized POLAR trial. Annals of Oncology, 33, S1257\u2013S1258. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.1646","DOI":"10.1016\/j.annonc.2022.07.1646"},{"key":"8737_CR25","doi-asserted-by":"publisher","unstructured":"Schaper T, Rezai M, Petruschke G, Gross B, Franzmann L, Darsow M. (2019) Efficiency of controlled cryotherapy in prevention of chemotherapy induced peripheral neuropathy (CIPN). Ann Oncol 30(Supplement_5):2019. https:\/\/doi.org\/10.1093\/annonc\/mdz265","DOI":"10.1093\/annonc\/mdz265"},{"key":"8737_CR26","doi-asserted-by":"publisher","unstructured":"Oneda E, Meriggi F, Zanotti L, Zaina E, Bigh\u00e8 S, Andreis F, Rueda S, Zaniboni A. (2020) Innovative approach for the prevention of chemotherapy-induced peripheral neuropathy in cancer patients: a pilot study with the Hilotherm device, the Poliambulanza Hospital experience. Integr Cancer Ther 19:1534735420943287. https:\/\/doi.org\/10.1177\/1534735420943287","DOI":"10.1177\/1534735420943287"},{"key":"8737_CR27","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"C Loprinzi","year":"2020","unstructured":"Loprinzi C, Lacchetti C, Bleeker J et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38:3325\u20133348. https:\/\/doi.org\/10.1200\/JCO.20.01399","journal-title":"J Clin Oncol"},{"issue":"7","key":"8737_CR28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/cncr.23333","volume":"112","author":"F Scott\u00e9","year":"2008","unstructured":"Scott\u00e9 F, Banu E, Medioni J et al (2008) Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer 112(7):1625\u20131631. https:\/\/doi.org\/10.1002\/cncr.23333","journal-title":"Cancer"},{"issue":"19","key":"8737_CR29","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","volume":"23","author":"F Scott\u00e9","year":"2005","unstructured":"Scott\u00e9 F, Tourani JM, Banu E et al (2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 23(19):4424\u20134429. https:\/\/doi.org\/10.1200\/JCO.2005.15.651","journal-title":"J Clin Oncol"},{"key":"8737_CR30","doi-asserted-by":"publisher","unstructured":"Sakurai M, Todaka K, Takada N, et al. (2009) Multicenter phase II study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity for the breast cancer patients (Kinki Multidisciplinary Breast Oncology Group: KMBOG-0605). In: https:\/\/doi.org\/10.1158\/0008-5472.sabcs-4093","DOI":"10.1158\/0008-5472.sabcs-4093"},{"key":"8737_CR31","doi-asserted-by":"publisher","unstructured":"Hayashi T, Fujita T, Mase T, et al. (2009) Phase II clinical study of protection of nail change and skin toxicity by using a frozen glove in Japanese patients with early breast cancer treated by docetaxel and cyclophosphamide (TC) [TBCRG-03 study]. In: https:\/\/doi.org\/10.1158\/0008-5472.sabcs-09-808","DOI":"10.1158\/0008-5472.sabcs-09-808"},{"key":"8737_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2016.00274","volume":"6","author":"R Sundar","year":"2017","unstructured":"Sundar R, Bandla A, Tan SSH et al (2017) Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: a pilot study. Front Oncol. 6:1\u201310. https:\/\/doi.org\/10.3389\/fonc.2016.00274","journal-title":"Front Oncol."},{"issue":"8","key":"8737_CR33","first-page":"4213","volume":"34","author":"T Ohno","year":"2014","unstructured":"Ohno T, Mine T, Yoshioka H et al (2014) Management of peripheral neuropathy induced by nab-paclitaxel treatment for breast cancer. Anticancer Res 34(8):4213\u20134216","journal-title":"Anticancer Res"},{"key":"8737_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-021-06477-0","volume":"192","author":"A Coolbrandt","year":"2022","unstructured":"Coolbrandt A, Vancoille K, Dejaeger E et al (2022) Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer. Breast Cancer Res Treat 192:293\u2013301. https:\/\/doi.org\/10.1007\/s10549-021-06477-0","journal-title":"Breast Cancer Res Treat"},{"key":"8737_CR35","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1200\/JCO.2005.04.0543","volume":"24","author":"JJ Lee","year":"2006","unstructured":"Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24:1633\u20131642","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08737-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:10:35Z","timestamp":1723612235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08737-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8737"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08737-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of the Canton of Zurich, Switzerland, granted approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"554"}}